Article Information
History
- January 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rachel M. Kratofil1,2,
- Trevor E. Randall3,
- Josefien W. Hommes1,2,
- Rehnuma Sejuty3,
- Jessica Chisholm3,4,
- Deepa Raju5,
- Mario Vargas5,
- P. Lynne Howell5,6,
- Gerald B. Pier7,
- Douglas W. Morck3,4,
- Joe J. Harrison3 and
- Paul Kubes1,2,*
- 1Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- 2Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- 3Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada
- 4Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, Alberta, Canada
- 5Program in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
- 6Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
- 7Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, United States
- ↵*Corresponding author, Email
: pkubes{at}ucalgary.ca
Posted January 23, 2023.
PNAG exopolysaccharide eradication gives neutrophils access to Staphylococcus aureus biofilm infections
